In contrast, in a cerebral ischemia model, CX3CL1/CX3CR1 downregulation significantly reversed cognitive deficits by inhibiting microglia activation and promoting oligodendrocyte progenitor cell maturation and myelin regeneration (Du et al., 2020). The gene discussed is CX3CL1; the disease is Cognitive impairment.